Progressive metastatic pheochromocytoma induced by multiple endocrine neoplasia type 2A with a lethal outcome

  • Koshiro Nishimoto
  • , Noriaki Lukas Santo
  • , Masato Yonamine
  • , Kazuhiro Takekoshi
  • , Go Kaneko
  • , Suguru Shirotake
  • , Hisayo Fukushima
  • , Yoshitaka Okada
  • , Masanori Yasuda
  • , Akihiro Sakurai
  • , Masafumi Oyama
  • , Kento Kanao

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)

Abstract

Introduction: Patients with multiple endocrine neoplasia type 2A (MEN2A) harboring a pathological variant in the RET gene are characterized by medullary thyroid carcinoma (MTC), pheochromocytoma, and hyperparathyroidism. Although pheochromocytoma is currently defined as a malignant tumor, MEN2A-associated pheochromocytoma is known to have a small risk of metastasis. Case presentation: The case was a 62-year-old Japanese male with bilateral pheochromocytoma, multiple metastases in the liver and bones, and a cardiac thrombus. Genetic testing revealed a pathological variant at codon 634 of the RET gene, thereby leading a diagnosis of MTC. We considered that the multiple metastases were due to MTC; however, a liver biopsy revealed metastasis of pheochromocytoma. Conclusion: When pheochromocytoma precedes MTC, the diagnosis of MEN2A may be difficult.

Original languageEnglish
Pages (from-to)459-463
Number of pages5
JournalIJU Case Reports
Volume5
Issue number6
DOIs
Publication statusPublished - 11-2022
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Urology

Fingerprint

Dive into the research topics of 'Progressive metastatic pheochromocytoma induced by multiple endocrine neoplasia type 2A with a lethal outcome'. Together they form a unique fingerprint.

Cite this